Capstone Asset Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$902K Buy
30,720
+120
+0.4% +$3.28K 0.03% 625
2017
Q1
$778K Buy
30,600
+1,560
+5% +$40.3K 0.02% 673
2016
Q4
$747K Buy
29,040
+4,360
+18% +$115K 0.02% 692
2016
Q3
$676K Sell
24,680
-360
-1% -$9.89K 0.02% 765
2016
Q2
$706K Sell
25,040
-160
-0.6% -$4.11K 0.02% 726
2016
Q1
$595K Buy
25,200
+1,720
+7% +$37.9K 0.02% 807
2015
Q4
$528K Buy
23,480
+3,112
+15% +$71K 0.02% 886
2015
Q3
$471K Buy
20,368
+2,880
+16% +$72.2K 0.01% 954
2015
Q2
$431K Buy
17,488
+1,156
+7% +$28.9K 0.01% 1058
2015
Q1
$409K Buy
16,332
+2,000
+14% +$47.5K 0.01% 1205
2014
Q4
$331K Sell
14,332
-200
-1% -$4.58K 0.01% 1315
2014
Q3
$340K Buy
14,532
+760
+6% +$17.8K 0.01% 1273
2014
Q2
$319K Sell
13,772
-544
-4% -$12K 0.01% 1349
2014
Q1
$306K Sell
14,316
-1,160
-7% -$26.1K 0.01% 1409
2013
Q4
$366K Sell
15,476
-11,548
-43% -$250K 0.01% 1372
2013
Q3
$541K Sell
27,024
-172,648
-86% -$3.28M 0.01% 1225
2013
Q2
$3.45M Buy
+199,672
New +$3.31M 0.09% 238

Other funds holding TECH

Capstone Asset Management's TECH Position: Q2 2017 in Review

Capstone Asset Management increased its Bio-Techne (TECH) stake by 0.39% in Q2 2017, buying an estimated $3.28K and bringing the position to 30,720 shares worth $902K. The position accounts for 0.03% of the portfolio, ranked #625.

Capstone Asset Management first reported a position in TECH in Q2 2013 and has held it in 17 quarters since. The position peaked at $3.45M in Q2 2013. 280 funds tracked by Wall St. Rank hold TECH as of Q2 2017.

  • Capstone Asset Management held 30,720 shares of Bio-Techne worth $902K as of Q2 2017.
  • Capstone Asset Management bought 120 Bio-Techne shares in Q2 2017, an estimated $3.28K.
  • Bio-Techne made up 0.03% of Capstone Asset Management's portfolio in Q2 2017, its #625 holding.
  • Capstone Asset Management first reported a position in Bio-Techne in Q2 2013 and has held it in 17 quarters since.
  • Capstone Asset Management's Bio-Techne position peaked at $3.45M in Q2 2013.
  • 280 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.